The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations

Thumbnail Image

Tarih

2019

Yazarlar

Süreli Yayın başlığı

Süreli Yayın ISSN

Cilt Başlığı

ISSN

Cilt

Sayı

Yayınevi

CIG MEDIA GROUP, LP

Özet

Açıklama

Anahtar kelimeler

Chronic myeloid leukemia, European LeukemiaNet \\(ELN\\), Imatinib, Tyrosine kinase inhibitor, Warning

Alıntı

URI

https://openaccess.acibadem.edu.tr/handle/11443/7984

Koleksiyonlar

WOS

Endorsement

Review

Supplemented By

Referenced By